Top Story

Walgreens to pay $270 million for overbilling prescription drugs, insulin pens

Walgreens to pay $270 million for overbilling prescription drugs, insulin pens
February 14, 2019

BLOG: HHS takes aim at PBMs

February 11, 2019
In the Aug. 25 “The Dry Eye” follow-up to my “Follow the Money” series on how drugs are priced in the marketplace, I noted that HHS announced a…

Amid new year drug price hikes, Congress calls on manufacturers to justify costs

January 25, 2019
In 2018, after President Donald Trump publicly condemned the pharmaceutical industry for skyrocketing prescription drug prices, several of the largest drug…

IND application accepted for Aerie's AR-1105

January 17, 2019
The FDA has accepted an investigational new drug application for AR-1105, a treatment candidate for macular edema due to retinal vein occlusion, Aerie Pharmaceuticals…
More Headlines »
Clinical Science

Analysis of Patient-Reported Barriers to Diabetic Retinopathy Follow-Up

Ophthalmic Surgery, Lasers and Imaging Retina, February 2019, Volume 50 Issue 2
Close follow-up of diabetic retinopathy (DR) has been linked to improved visual outcomes. This study elucidates…
More »

Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2

This activity is supported by an educational grant from Genentech, Inc.

The integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapy into management algorithms for…
More »
Meeting News Coverage

VIDEO: Important coding changes in 2016 for glaucoma and retina

January 21, 2016
More »